Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Number of holders
-
311
-
Total 13F shares, excl. options
-
19,759,934
-
Shares change
-
-3,639,082
-
Total reported value, excl. options
-
$624,634,834
-
Value change
-
-$149,931,968
-
Put/Call ratio
-
88%
-
Number of buys
-
94
-
Number of sells
-
208
-
Price
-
$31.49
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q2 2022
As of 30 Jun 2022 ARK ETF TR - GENOMIC REV ETF (ARKG) had 446 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,759,934 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, LPL Financial LLC, UBS Group AG, Avidity Partners Management LP, GOLDMAN SACHS GROUP INC, BNP PARIBAS ARBITRAGE, SA, COMMONWEALTH EQUITY SERVICES, LLC, and STATE OF WISCONSIN INVESTMENT BOARD.
This table shows 446 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.